报价延迟最少15分钟:2025/09/16 23:16 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
65.16 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
2.04/4.39
|
|
企业价值
15.57B
|
| 资产负债 |
|
每股账面净值
42.01
|
| 现金流量 |
|
现金流量率
0.06
|
| 损益表 |
|
收益
3.90B
|
|
每股收益
17.68
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/09/16 23:16 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical,founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market. |
